Suppr超能文献

韩国主要下肢骨科手术后的血栓预防和并发症趋势:国家健康保险索赔数据。

Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data.

机构信息

Department of Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.

Department of Statistics, Dongguk University-, Seoul, Republic of Korea.

出版信息

Thromb Res. 2017 Jul;155:48-52. doi: 10.1016/j.thromres.2017.04.023. Epub 2017 Apr 26.

Abstract

BACKGROUND

In Western countries, prophylaxis for venous thromboembolism (VTE) following major lower limb orthopaedic surgeries is recommended. However, that has not been the case in Asian countries, where the reported incidence of postoperative VTE has been low. The present study examined trends in VTE prophylaxis prescriptions and related complications following major lower limb orthopaedic surgeries in South Korea.

DESIGN/PARTICIPANTS: Using claim data from the National Health Insurance Corporation, 263,664 patients aged 65years or older who underwent major orthopaedic surgeries (total hip arthroplasty [THA], total knee arthroplasty [TKA], or hip fracture surgery [HFS]) between 2008 and 2012 were included.

RESULT

The prescription rate for VTE prophylaxis has increased from 62.4% in 2008 to 75.4% in 2012 (P<0.001). The prescription rate for new oral anticoagulants following THA and TKA has increased drastically since 2010, while that following HFS has not. Instead, prophylactic use of aspirin or low molecular weight heparin has increased in HFS cases. The rate of postoperative complications has significantly increased annually only in HFS: VTE (P=0.018) and brain haemorrhage or gastrointestinal bleeding (P=0.019).

CONCLUSION

This result could suggest the need for more studies about the use of VTE prophylactic medicines following HFS.

摘要

背景

在西方国家,建议对主要下肢骨科手术后的静脉血栓栓塞症(VTE)进行预防。然而,亚洲国家并非如此,这些国家术后 VTE 的报告发生率较低。本研究调查了韩国主要下肢骨科手术后 VTE 预防处方和相关并发症的趋势。

设计/参与者:使用国民健康保险公司的索赔数据,纳入了 2008 年至 2012 年间 263664 名年龄在 65 岁或以上接受主要骨科手术(全髋关节置换术 [THA]、全膝关节置换术 [TKA] 或髋部骨折手术 [HFS])的患者。

结果

VTE 预防处方的开具率从 2008 年的 62.4%增加到 2012 年的 75.4%(P<0.001)。自 2010 年以来,THA 和 TKA 后新型口服抗凝剂的处方率大幅增加,而 HFS 后则没有。相反,在 HFS 病例中,阿司匹林或低分子肝素的预防性使用有所增加。仅在 HFS 中,术后并发症的发生率每年显著增加:VTE(P=0.018)和脑出血或胃肠道出血(P=0.019)。

结论

这一结果可能表明需要更多研究 HFS 后 VTE 预防药物的使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验